Trump Tariffs may not hurt Indian companies, according to Morgan Stanley. Sun Pharma may see an impact. (File) Show Quick Read Summary is AI Generated. Newsroom Reviewed

United States President Donald Trump's plan to impose 100% tariffs on imported branded and patented pharmaceuticals is unlikely to hurt Indian companies, according to Morgan Stanley.

In its latest note, the firm did flag potential risks to companies that have exposure to speciality drug exposure, notably mentioning Sun Pharma.

ALSO READ

Sun Pharma Leads Pharma Stocks Decline After Trump Hikes Tariff To 100% Opinion Sun Pharma Leads Pharma Stocks Decline After Trump Hikes Tariff To 100% Read More

The tariff, which was announced by Donald Trump on Truth Social, will take effect from October 1, 2025. The tarif

See Full Page